Search
Skip to Search Results-
Spring 2011
Chronic obstructive pulmonary disease (COPD) is expected to become the third most common cause of mortality in the world (GOLD Committee, 2009). COPD management continues to play a large role in everyday medical practice and inhalation therapy will continue to be a mainstay of COPD treatment....
-
Pharmacist Management of Hypertension: An Examination of Clinical and Economic Outcomes and Remuneration for Expanded Services
DownloadSpring 2014
Background: One-third of Canadian adults with hypertension remain uncontrolled. As drug therapy experts, pharmacists can play a role in addressing this challenge, particularly when utilizing prescribing authorization in Alberta. However, the clinical effectiveness of pharmacist management of...
-
Spring 2020
In 2007, Additional Prescribing Authorization (APA) was introduced in Alberta, which allows pharmacists to independently initiate prescriptions and prescribe to manage ongoing therapy. Pharmacist prescribing has also been shown to have positive patient outcomes in a variety of health conditions....